换一批
换一批Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
作者：
Lieske H,Schrijver [1]
;
Antonis C,Antoniou [2]
;
Håkan,Olsson [3]
;
Thea M,Mooij [1]
;
Marie-José,Roos-Blom [1]
;
Leyla,Azarang [1]
;
Julian,Adlard [4]
;
Munaza,Ahmed [5]
;
Daniel,Barrowdale [2]
;
Rosemarie,Davidson [6]
;
Alan,Donaldson [7]
;
Ros,Eeles [8]
;
D Gareth,Evans [9]
;
Debra,Frost [2]
;
Alex,Henderson [10]
;
Louise,Izatt [11]
;
Kai-Ren,Ong [12]
;
Valérie,Bonadona [13]
;
Isabelle,Coupier [14]
;
Laurence,Faivre [15]
;
Jean-Pierre,Fricker [16]
;
Paul,Gesta [17]
;
Klaartje,van Engelen [18]
;
Agnes,Jager [19]
;
Fred H,Menko [20]
;
Marian J E,Mourits [21]
;
Christian F,Singer [22]
;
Yen Y,Tan [22]
;
Lenka,Foretova [23]
;
Marie,Navratilova [23]
;
Rita K,Schmutzler [24]
;
Carolina,Ellberg [25]
;
Anne-Marie,Gerdes [26]
;
Trinidad,Caldes [27]
;
Jacques,Simard [28]
;
Edith,Olah [29]
;
Anna,Jakubowska [30]
;
Johanna,Rantala [31]
;
Ana,Osorio [32]
;
John L,Hopper [33]
;
Kelly-Anne,Phillips [34]
;
Roger L,Milne [35]
;
Mary,Beth Terry [36]
;
Catherine,Noguès [37]
;
Christoph,Engel [38]
;
Karin,Kast [39]
;
David E,Goldgar [40]
;
Flora E,van Leeuwen [1]
;
Douglas F,Easton [2]
;
Nadine,Andrieu [41]
;
Matti A,Rookus [42]
;
Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study
作者单位：
Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
[1]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
[2]
Department of Oncology, Lund University Hospital, Lund, Sweden.
[3]
Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
[4]
North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
[5]
Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom.
[6]
Department of Clinical Genetics, St. Michael's Hospital, Bristol, United Kingdom.
[7]
Oncogenetics Team, The Institute of Cancer Research, London, United Kingdom.
[8]
Division of Evolution and Genomic Sciences, Department of Genomic Medicine, Manchester Academic Health Sciences Centre, Manchester University, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
[9]
Centre for Life, Institute of Genetic Medicine, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom.
[10]
Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
[11]
West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Edgbaston, Birmingham, United Kingdom.
[12]
Université Claude Bernard Lyon 1, Villeurbanne, France; Centre National de la Recherche Scientifique, Unités Mixtes de Recherche, Lyon, France; Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France.
[13]
Centre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, France; Service de Génétique médicale et Oncogénétique, Montpellier, France; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche en Cancérologie de Marseille Val d'Aurel, Montpellier, France.
[14]
Genomic and Immunotherapy Medical Institute, Hôpital d'Enfants, Centre Hospitalier Universitaire de Dijon, Dijon, France; Unité d'Oncogénétique, Centre de Lutte Contre le Cancer Georges François Leclerc, Dijon, France.
[15]
Unité d' Oncogénétique, Centre Paul Strauss, Strasbourg, France.
[16]
Service d'Oncogénétique Régional Poitou-Charentes, Centre Hospitalier Georges Renon, Niort, France.
[17]
Department of Clinical Genetics, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
[18]
Department of Medical Oncology, Family Cancer Clinic, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
[19]
Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands.
[20]
Department of Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
[21]
Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
[22]
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
[23]
Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
[24]
Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
[25]
Department of Clinical Genetics, Rigshospitalet, København, Denmark.
[26]
Molecular Oncology Laboratory, Hospital Clinico San Carlos, Instituto de Investigación Hospital Clínico San Carlos, Centro de Investigación Biomédica en Red de Cáncer, Martin Lagos, Madrid, Spain.
[27]
Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, Québec, Canada.
[28]
Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
[29]
Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
[30]
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
[31]
Human Genetics Group, Centro Nacional De Investigaciones Oncologicas, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.
[32]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
[33]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia; Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Parkville, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.
[34]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
[35]
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
[36]
Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France; Institut National de la Santé et de la Recherche Médicale, Institut de Recherche pour le Développement, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Aix-Marseille University, Marseille, France.
[37]
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany.
[38]
Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
[39]
Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT.
[40]
Institut National de la Santé et de la Recherche Médicale, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, Paris, France; Paris Sciences et Lettres University, Paris, France.
[41]
Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.rookus@nki.nl.
[42]
主题词
成年人(Adult);BRCA1蛋白质(BRCA1 Protein);BRCA2蛋白质(BRCA2 Protein);队列研究(Cohort Studies);避孕药, 口服(Contraceptives, Oral);欧洲(Europe);女(雌)性(Female);随访研究(Follow-Up Studies);疾病遗传易感性(Genetic Predisposition to Disease);人类(Humans);中年人(Middle Aged);突变(Mutation);卵巢肿瘤(Ovarian Neoplasms);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies)
DOI
10.1016/j.ajog.2021.01.014
PMID
33493488
发布时间
2024-02-14
- 浏览3
American journal of obstetrics and gynecology
American journal of obstetrics and gynecology
51.e1-51.e17页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
